GSTM1 and COVID-19: After adjusting for confounding variables like healthcare access, income, and testing rates, the analysis found that a higher frequency of the GSTT1-null genotype was unexpectedly associated with lower COVID-19 mortality and fatality rates (p = 0.001 and p = 0.005), while GSTM1-null genotype showed no significant correlation.